BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bossi P, Platini F. Radiotherapy plus EGFR inhibitors: synergistic modalities. Cancers Head Neck 2017;2:2. [PMID: 31093349 DOI: 10.1186/s41199-016-0020-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Nair S, Bonner JA, Bredel M. EGFR Mutations in Head and Neck Squamous Cell Carcinoma. Int J Mol Sci 2022;23:3818. [PMID: 35409179 DOI: 10.3390/ijms23073818] [Reference Citation Analysis]
2 Anand AK, Agarwal JP, D'Cruz A, Dattatreya PS, Goswami C, Joshi A, Julka PK, Noronha V, Prabhash K, Rao RR, Kumar R, Toprani R, Saxena V. Evolving multidisciplinary treatment of squamous cell carcinoma of the head and neck in India. Cancer Treat Res Commun 2021;26:100269. [PMID: 33338859 DOI: 10.1016/j.ctarc.2020.100269] [Reference Citation Analysis]
3 Li H, Xing S, Xu J, He Y, Lai Y, Wang Y, Zhang G, Guo S, Deng M, Zeng M, Liu W. Aptamer-based CRISPR/Cas12a assay for the ultrasensitive detection of extracellular vesicle proteins. Talanta 2021;221:121670. [PMID: 33076176 DOI: 10.1016/j.talanta.2020.121670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lee TY, Tseng YH. The Potential of Phytochemicals in Oral Cancer Prevention and Therapy: A Review of the Evidence. Biomolecules 2020;10:E1150. [PMID: 32781654 DOI: 10.3390/biom10081150] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]